Skip to content

ASHP® Injectable Drug Information™

Hero Background Image

Title Details

2025 Ed.

ASHP®

ISBN-13: 978-1-58528-743-7

eISBN-13: 978-1-58528-744-4

Drug Information, Point of Care, Nursing, Pharmacy/Pharmacology

Additional Details

Description
Audience
Doody's Reviews

Backed by quality, peer-reviewed published literature, ASHP® Injectable Drug Information™ has been one of pharmacy’s most trusted resources for more than four decades.

Authored under the editorial authority of AHFS Drug Information® and published by ASHP, it is the global gold standard for IV compatibility and stability information.

The 2025 Edition of the industry’s go-to guide is newly updated with the latest information, ASHP’s Standardize 4 Safety (S4S) concentration standards including new Adult and Pediatric PCA and Epidural standard concentrations, the full list of the AHFS® Pharmacologic-Therapeutic Classification© system, 25 new monographs, and more than 270 new references for a total of over 25,000 total compatibility pairs.

ASHP® Injectable Drug Information™ 2025 features more than 420 monographs, including:

  • • Sulbactam Sodium and Durlobactam Sodium
  • • Rezafungin Acetate
  • • Ublituximab
  • • Mosnetuzumab
  • • Teplizumab
  • • Terlipresssin Acetate
  • • Tecovirimat

Table of Contents

Similar Resources

Cards Background

The Power of A Digital Library

TDS Health titles provide the latest healthcare information in a customizable and convenient format. STAT!Ref goes where you go, accessible by desktop, laptop, wireless or web-enabled mobile devices. Harness the power of learning in you hands.

1
TEAM DEDICATED TO YOUR LEARNING SUCCESS
50
Healthcare Disciplines
500 +
DIGITAL MEDICAL TITLES AVAILABLE
CTA Background Image